[Finerenone (CKD stage 3 and 4) – Addendum to Commission A23-15]
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018005117
German
Original Title:
Finerenon (Niereninsuffizienz, Stadium 3 und 4) - Addendum zum Projekt A23-15 (Dossierbewertung)
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/a23-70.html
Year Published:
2023
URL for published report:
https://www.iqwig.de/download/a23-70_finerenon_addendum-zum-projekt-a23-15_v1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Renal Insufficiency, Chronic
- Diabetes Mellitus, Type 2
- Naphthyridines
Keywords
- Finerenone
- Renal Insufficiency – Chronic
- Diabetes Mellitus – Type 2
- Benefit Assessment
- NCT02545049
- NCT02540993
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.